Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2000
11/09/2000CA2372493A1 Steroid derivatives
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372279A1 Compositions containing benzimidazolones and progestogens
11/09/2000CA2372223A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000CA2372220A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000CA2372176A1 Novel prolines as antimicrobial agents
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/09/2000CA2372073A1 Glycine cleavage system inhibitors as potential antipsychotics
11/09/2000CA2371946A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371726A1 Cyclocarbamate derivatives as progesterone receptor modulators
11/09/2000CA2371671A1 Pyrimidinone compounds
11/09/2000CA2371651A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
11/09/2000CA2371638A1 Indoline derivatives as progesterone antagonists
11/09/2000CA2371633A1 Thio-oxindole derivatives
11/09/2000CA2371632A1 Cyclocarbamate and cyclic amide derivatives
11/09/2000CA2371629A1 3,3-substituted indoline derivatives
11/09/2000CA2371618A1 Cyclic amide compounds, their production and use
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2371391A1 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
11/09/2000CA2371231A1 Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate
11/09/2000CA2371215A1 New compounds
11/09/2000CA2370111A1 Optical probes and assays
11/09/2000CA2369371A1 Death domain containing receptor 5
11/09/2000CA2368801A1 Conjugates as therapies for cancer and prostate diseases
11/09/2000CA2368748A1 X-ray guided drug delivery
11/09/2000CA2366805A1 Benzimidazolones and analogues and their use as progesterone receptor ligands
11/09/2000CA2365900A1 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
11/09/2000CA2365782A1 Treatment of female arousal disorder
11/09/2000CA2365440A1 Human ion channel proteins
11/09/2000CA2365212A1 Substituted 3-cyano-[1.7],[1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases
11/09/2000CA2336362A1 Anti-irritant compositions containing a cyclic 2'-deoxy-nucleotide
11/08/2000EP1050534A1 2,3-methano-amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
11/08/2000EP1050530A1 1-Aza-2-alkyl-6-aryl-cycloalkanes usefull as memory enhancers
11/08/2000EP1050309A1 Neurotrophic factor secretion promoters
11/08/2000EP1050307A1 CCR4 antagonists in sepsis
11/08/2000EP1050306A1 CYTOKINE INDUCERS COMPRISING M161Ag
11/08/2000EP1049780A1 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/08/2000EP1049773A1 Inhibition of cytokine production
11/08/2000EP1049770A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049714A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049708A1 Meth1 and meth2 polynucleotides and polypeptides
11/08/2000EP1049703A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049699A1 Azolo triazines and pyrimidines
11/08/2000EP1049698A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
11/08/2000EP1049697A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
11/08/2000EP1049696A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
11/08/2000EP1049695A1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049691A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
11/08/2000EP1049689A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
11/08/2000EP1049677A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
11/08/2000EP1049675A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049673A1 Heterocyclic amidines as callicrein protease inhibitors
11/08/2000EP1049671A1 Azetidinecarboxamide derivatives for the treatment of cns disorders
11/08/2000EP1049670A1 Azetidinecarboxamide derivatives for treating cns disorders
11/08/2000EP1049664A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/08/2000EP1049490A2 Method for inhibiting cd95-independent apoptosis in aids
11/08/2000EP1049487A2 Method for treating acute intermittent porphyria (aip) and other porphyric diseases
11/08/2000EP1049485A1 Enhancement of hematopoietic cells
11/08/2000EP1049478A1 Composition containing propargylamine for enhancing cancer therapy
11/08/2000EP1049476A1 Pharmaceutical compositions for mucolysis and treatment of inflammation
11/08/2000EP1049475A1 KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA)
11/08/2000EP1049472A1 Antagonists of gonadotropin releasing hormone
11/08/2000EP1049471A1 Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids
11/08/2000EP1049465A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
11/08/2000EP1049441A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
11/08/2000EP0861231B1 L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthaseinhibitors
11/08/2000EP0787000B1 Quinazolinone pharmaceuticals and use thereof
11/08/2000EP0769006B1 Small molecule inhibitors of rotamase enzyme activity
11/08/2000EP0687180B1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
11/08/2000EP0637307B1 Imidazole, triazole and tetrazole derivatives
11/08/2000CN1272886A Polynucleotide encoding polypeptide having heparanase activity and expression of same in transduced cells
11/08/2000CN1272884A Adipocyte-specific protein homologs
11/08/2000CN1272844A Benzo (5,6) cyclohepta (1,2-B) pyridine derivatives as farnesyl protein transferase inhibitors
11/08/2000CN1272842A 2-acylaminopropanamines as tachykinin receptor antagonists
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1272792A Herbal extract composition and method with immune-boosting capability
11/08/2000CN1272789A Pharmaceutical compositions for oral administration of molecular iodine
11/08/2000CN1272538A Quick high-effective separation and purification method of virus related to rocombinant adenovirus and its application
11/08/2000CN1272493A Novel amino-triazole compound, its preparation method and drug composition containing them
11/08/2000CN1058262C Novel 1-phenylalkanone 5-HT4 receptor ligands
11/08/2000CN1058190C Memory oral liquor
11/08/2000CN1058167C Aconite oral liquor and preparation method thereof
11/08/2000CN1058166C Drug for curing leukopenia and radiation damage
11/08/2000CN1058162C Pearl oral liquor capable of clearing away heart-fire
11/07/2000US6143886 Azepinone compounds useful in the inhibition of ACE and NEP
11/07/2000US6143878 Sox-9 gene and protein and use in the regeneration of bone or cartilage
11/07/2000US6143870 Thrombin receptor homolog
11/07/2000US6143867 Amino acid sequence; for diagnosis, prevention, and treatment of late-phase allergic/inflammatory reactions, eosinophilias, parasitic infections, conditions associated with placental derived-basic protein accumulation in pregnancy
11/07/2000US6143864 Peptides
11/07/2000US6143797 Use of sodium 2-mercaptoethanesulfonate in surgery
11/07/2000US6143789 Enantiomorphs
11/07/2000US6143783 Amino acids
11/07/2000US6143782 Anti-inflammatory and anti-asthma treatment with reduced side effects
11/07/2000US6143779 Benzofuranone derivatives and a method for producing them
11/07/2000US6143777 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
11/07/2000US6143776 Enzyme inhibitors of thymidylate synthase